Key facts
- Notable investors include SocialX Acceleration, Okinawa Science and Technology Promotion Center, STARTUP LAB RYUDAI.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Ryuwell
- ·The full record, as it builds
Funding rounds
No funding rounds for Ryuwell are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ryuwell
Operator of a healthcare technology company intended to integrate medicine and advanced technology to develop services for preventive care, smart online diagnostics and medical data innovation. The company offers AI-driven healthcare services co-developed with medical researchers and institutions, enabling customers to access reliable tools for early detection, prevention and management of conditions such as dementia and mental health disorders.
- Sector
- Healthcare
- HQ
- Naha, Japan
- Founded
- 2024
- Website
- ryuwell.com/
- Ownership
- Privately Held (backing)
Ryuwell doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ryuwell shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ryuwell in its N-PORT filings yet. We sweep new filings monthly.